Design Therapeutics (DSGN) Earnings Date & Reports
A.I. Advisor
published Earnings
DSGN is expected to report earnings to rise 17.48% to -24 cents per share on November 05
Q3'24
Est.
$-0.25
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.06
Q4'23
Beat
by $0.10
Q3'23
Beat
by $0.13
The last earnings report on August 05 showed earnings per share of -20 cents, beating the estimate of -23 cents. With 135.95K shares outstanding, the current market capitalization sits at 301.79M.